Logo

Etienne-Emile Baulieu, Inventor of Abortion Pill, Passes Away at 98

Etienne-Emile Baulieu, the French endocrinologist who developed the abortion pill RU-486, died at 98. His medical advancements transformed women's reproductive rights worldwide. Baulieu also contributed to hormone research, neurodegenerative disease studies, and received numerous honors for his scientific work and dedication to improving human health.

Etienne-Emile Baulieu, Inventor of Abortion Pill, Passes Away at 98

Renowned Scientist Etienne-Emile Baulieu Dies at 98

Etienne-Emile Baulieu, the French endocrinologist famed for inventing the abortion pill RU-486, passed away at his home in Paris at the age of 98. His institute announced his death, highlighting his impactful scientific and social contributions.

Scientific Contributions and Legacy

Baulieu was internationally recognized for his groundbreaking work on steroid hormones, which brought significant advances in medicine and women's reproductive rights. His research was driven by a commitment to scientific progress, women's freedom, and improving human health.

Born as Etienne Blum on December 12, 1926, in Strasbourg, he adopted the name Emile Baulieu while participating in the French Resistance during World War II at the young age of 15. After earning a medical doctorate in 1955 and a science doctorate in 1963, Baulieu founded a pioneering hormone research unit at the French National Institute of Health and Medical Research (INSERM), which he led until 1997.

The Abortion Pill: A Revolutionary Development

In 1982, Baulieu developed the abortion pill RU-486, which revolutionized voluntary medical termination of pregnancy by providing a non-invasive and less traumatic alternative to surgery. This innovation transformed the lives of millions of women worldwide by offering a safer and psychologically less distressing option.

His discovery was met with significant opposition, including criticism and threats from those against abortion rights. Despite ongoing challenges and legal restrictions in some countries, RU-486 remains the most widely used method for medical abortion in several regions, including the United States.

Further Research and Honors

Beyond RU-486, Baulieu investigated the hormone DHEA and its anti-aging properties, contributing to understanding neurosteroids and their effects on the nervous system. His work also led to developing treatments for depression, currently undergoing clinical trials across multiple university hospitals.

In 2008, he established the Institut Baulieu, dedicated to researching neurodegenerative diseases such as Alzheimer's, aiming to prevent and treat these conditions.

Recognition and Personal Life

Baulieu received numerous accolades, including the Grand Crosses of the Légion d'honneur and the Ordre national du Mérite. He was elected to the French Academy of Sciences in 1982 and served as its president in 2003 and 2004. He also contributed to national advisory committees on life sciences and health.

French President Emmanuel Macron honored Baulieu as a courageous and progressive figure who greatly advanced women's rights and global science. Baulieu's personal life included two marriages; after the passing of his first wife, Yolande Compagnon, he remarried Simone Harari Baulieu. He is survived by three children, eight grandchildren, and nine great-grandchildren.

Breakthrough Mouse Model Unveils Secrets of Smell Regeneration
Breakthrough Mouse Model Unveils Secrets of Smell Regeneration

A team at Tufts University has devised a simple 3D mouse model to study the regeneration of olfactory neurons. Contrary to past beliefs, certain dormant stem cells play active roles in repairing and generating nerve tissue linked to smell. The model also reflects age-related decline in neuron growth, paving the way for future treatments of smell loss.

Trump Administration Cuts $766M Funding to Moderna for Bird Flu Vaccine Projects
Trump Administration Cuts $766M Funding to Moderna for Bird Flu Vaccine Projects

The Trump administration has retracted $766 million in funding awarded to Moderna for developing vaccines targeting pandemic influenza viruses, including H5N1 bird flu. Despite positive vaccine trial results and proven safety of Moderna’s mRNA technology, health officials have raised concerns. Meanwhile, the new highly contagious COVID-19 variant NB.1.81 has been detected in several US states, adding to public health complexities.

China's Biotech Industry Gains Momentum, Threatening U.S. Lead
China's Biotech Industry Gains Momentum, Threatening U.S. Lead

Amidst intense U.S.-China competition, China is poised to overtake the U.S. in biotechnology due to its flexible regulatory framework, dominant pharmaceutical production, and large talent pool. The U.S. faces challenges from layoffs in key biotech hubs and lacks a unified strategy, while experts urge increased federal investment to maintain leadership. Global collaboration in biotech remains critical despite geopolitical tensions.

Sarepta Shares Plummet 40% Amid FDA Scrutiny Over Gene Therapy Safety
Sarepta Shares Plummet 40% Amid FDA Scrutiny Over Gene Therapy Safety

Shares of Sarepta Therapeutics took a significant hit after the FDA signaled it may halt shipments of Elevidys, a gene therapy for Duchenne Muscular Dystrophy tied to multiple patient deaths. The therapy’s safety concerns come amidst controversial approvals and uncertain benefits, putting Sarepta's financial future and patient hope in jeopardy. Experts highlight the broader challenges of regulating breakthrough gene therapies balancing innovation with patient safety.

Etienne-Emile Baulieu, Inventor of Abortion Pill, Dies at 98
Etienne-Emile Baulieu, Inventor of Abortion Pill, Dies at 98

Etienne-Emile Baulieu, who developed mifepristone, the abortion pill, passed away at 98. A World War II resistance fighter turned renowned scientist, Baulieu's research advanced women's reproductive rights globally. He continued groundbreaking studies on Alzheimer's and depression late into life. Honored with top French and international awards, Baulieu's legacy endures in medicine and advocacy.

UK Scientists Embark on Groundbreaking Human DNA Synthesis Project
UK Scientists Embark on Groundbreaking Human DNA Synthesis Project

The UK has launched the Synthetic Human Genome Project, funded by £10 million, aiming to construct human DNA artificially. Building on the original Human Genome Project, this initiative seeks to revolutionize treatments for genetic and age-related diseases by synthesizing chromosomes. However, alongside the scientific promise, the project faces significant ethical debates over potential misuse and the need for strict oversight involving sociologists and ethicists.

‘Gwada Negative’: Caribbean Woman Identified as Sole Carrier of New Blood Type
‘Gwada Negative’: Caribbean Woman Identified as Sole Carrier of New Blood Type

Scientists have identified a new blood group system called 'Gwada negative' in a woman from Guadeloupe, making her the only known carrier worldwide. Discovered after 15 years and advanced DNA sequencing, this blood type marks the 48th recognized system globally, offering important insights for rare blood transfusion care.

Trump Administration Cancels $766 Million Moderna Contract for Bird Flu Vaccine
Trump Administration Cancels $766 Million Moderna Contract for Bird Flu Vaccine

The Trump administration has retracted $766 million in funding previously granted to Moderna for its development of an mRNA-based vaccine targeting H5N1 bird flu. The funds, allocated via BARDA, were withdrawn despite Moderna reporting positive interim trial outcomes. The H5N1 virus poses a potential pandemic risk due to ongoing mutations. Moderna had planned late-stage trials supported by the canceled funds.

Neuralink Secures $650 Million to Advance Brain-Computer Interface Technology
Neuralink Secures $650 Million to Advance Brain-Computer Interface Technology

Neuralink, Elon Musk's brain technology firm, has raised $650 million to develop its brain-computer interface devices that translate neural signals into commands for external devices. Its Telepathy system, using ultra-thin threads implanted in the brain, has already helped five patients control devices via thought. Neuralink is conducting multiple clinical trials and has gained FDA breakthrough status for its vision restoration technology, signaling significant advancements in patient care and AI integration.

Ukrainian Drones Strike Siberian Airbase, Destroy Over 40 Russian Aircraft
Ukrainian Drones Strike Siberian Airbase, Destroy Over 40 Russian Aircraft

Ukraine conducted a major drone attack on June 1, 2025, hitting a military airbase in the Irkutsk region of Siberia, far from active frontlines. More than 40 Russian planes, including bombers and an A-50 early warning aircraft, were reportedly destroyed during simultaneous strikes on four airbases. This operation, part of the 'Pavutyna' campaign, aims to reduce Russia's long-range aerial capabilities. Emergency responders acted swiftly, and launch sites were blocked. Diplomatically, Kyiv accepted Russia's proposal for fresh talks in Istanbul to pursue a ceasefire and prisoner exchanges.

Trump Considers Pardoning Sean 'Diddy' Combs Amid Federal Charges
Trump Considers Pardoning Sean 'Diddy' Combs Amid Federal Charges

Sean 'Diddy' Combs, facing serious federal charges such as sex trafficking and racketeering, could potentially receive a pardon from former President Donald Trump. Trump expressed willingness to review the case facts before making a decision, despite no formal pardon request. Combs' legal challenges stem from allegations of coerced participation in sexual acts and face possible life imprisonment, while Trump continues to actively utilize his pardon authority.